http://www.unboundmedicine.com/medline/ebm/research/TargretinUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19016373/full_citation/Evaluation_of_the_efficacy_of_the_combination_of_oral_bexarotene_and_methotrexate_for_the_treatment_of_early_stage_treatment_refractory_cutaneous_T_cell_lymphoma_Kannangara AP, Levitan D, Fleischer AB 
Evaluation of the efficacy of the combination of oral bexarotene and methotrexate for the treatment of early stage treatment-refractory cutaneous T-cell lymphoma. [JOURNAL ARTICLE]
J Dermatolog Treat 2008 Nov 18.:1-8.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18985183/full_citation/Gateways_to_clinical_trials_Tomillero A, Moral MA 
Gateways to clinical trials. [Journal Article]
Methods Find Exp Clin Pharmacol 2008 Sep; 30(7):543-88.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18957410/full_citation/Rexinoid_induced_expression_of_IGF_binding_protein_6_requires_RARbeta__dependent_permissive_co_operation_of_retinoid_receptors_and_AP_1_Uray IP, Shen Q, Seo HS, et al. 
Rexinoid-induced expression of IGF binding protein-6 requires RARbeta -dependent permissive co-operation of retinoid receptors and AP-1. [JOURNAL ARTICLE]
J Biol Chem 2008 Oct 28.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18941435/full_citation/Mechanisms_related_to_the_pathophysiology_and_management_of_central_hypothyroidism_Yamada M, Mori M 
Mechanisms related to the pathophysiology and management of central hypothyroidism. [JOURNAL ARTICLE]
Nat Clin Pract Endocrinol Metab 2008 Oct 21.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18836291/full_citation/Successful_treatment_of_relapsed_lymphomatoid_granulomatosis_with_bexarotene_Berg SE, Downs LH, Torigian DA, et al. 
Successful treatment of relapsed lymphomatoid granulomatosis with bexarotene. [JOURNAL ARTICLE]
Cancer Biol Ther 2008 Oct 21; 7(10)
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18786257/full_citation/Transcriptomic_signature_of_the_chemopreventive_Bexarotene__Rexinoid_LGD1069__on_mammary_gland_from_three_transgenic_mouse_mammary_cancer_models_Abba MC, Hu Y, Levy CC, et al. 
Transcriptomic signature of the chemopreventive Bexarotene (Rexinoid LGD1069) on mammary gland from three transgenic mouse mammary cancer models. [JOURNAL ARTICLE]
BMC Med Genomics 2008 Sep 11; 1(1):40.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18773928/full_citation/Retinoids_regulate_TGFbeta_signaling_at_the_level_of_Smad2_phosphorylation_and_nuclear_accumulation_Hoover LL, Burton EG, O'Neill ML, et al. 
Retinoids regulate TGFbeta signaling at the level of Smad2 phosphorylation and nuclear accumulation. [JOURNAL ARTICLE]
Biochim Biophys Acta 2008 Aug 13.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18769114/full_citation/Potential_for_all_trans_retinoic_acid_[tretinoin]_to_enhance_interferon_alpha_treatment_response_in_chronic_myelogenous_leukemia_melanoma_myeloma_and_renal_cell_carcinoma_Kast RE 
Potential for all-trans retinoic acid [tretinoin] to enhance interferon-alpha treatment response in chronic myelogenous leukemia, melanoma, myeloma and renal cell carcinoma. [JOURNAL ARTICLE]
Cancer Biol Ther 2008 Oct 7; 7(10)
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18765556/full_citation/A_phase_I_study_of_bexarotene_a_retinoic_x_receptor_agonist_in_non_m3_acute_myeloid_leukemia_Tsai DE, Luger SM, Andreadis C, et al. 
A phase I study of bexarotene, a retinoic x receptor agonist, in non-m3 acute myeloid leukemia. [Journal Article]
Clin Cancer Res 2008 Sep 1; 14(17):5619-25.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18765520/full_citation/Expanding_the_use_of_retinoids_in_acute_myeloid_leukemia:_spotlight_on_bexarotene_McNamara S, Miller WH 
Expanding the use of retinoids in acute myeloid leukemia: spotlight on bexarotene. [Journal Article]
Clin Cancer Res 2008 Sep 1; 14(17):5311-3.
Full Citation | Find Related Articles